SureTrader SPDR Advertisement
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator flaflyersfan, Doubledown22, Stock Barber, vikingzskillz, Valiant, baryoboy
Search This Board:
Last Post: 8/29/2015 10:33:21 AM - Followers: 459 - Board type: Free - Posts Today: 24

MAJOR NEWS HEADLINE ::::::::::::::::::: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B


                        


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care
http://www.prnewswire.com/news-releases/coopervision-inc-seeks-intermediary-as-ep-global-communications-inc-opens-negotiations-at-11b-300057706.html

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request
http://www.prnewswire.com/news-releases/coopervision-inc-asks-ep-global-communications-inc-to-grant-option-to-license-immediately-300050979.html

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
LINKS TO SHARE RETIREMENT
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED  https://twitter.com/EPGLMed
Follow EPGL on the WEB at http://www.epglmed.com





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
Wiki
EPGL News: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 03/30/2015 01:11:00 PM
PostSubject
#85082  Sticky Note Google's Smart Contact Lens Challenged by EPGL vikingzskillz 08/18/15 12:39:17 AM
#81282  Sticky Note Google, Novartis and EPGL in Race to Develop Doubledown22 07/22/15 11:40:35 AM
#79335  Sticky Note July 29,2013 - Self Powered Contact Lens judypudy 06/05/15 10:31:01 PM
#55008  Sticky Note New Investor Q&A H8ster 07/21/14 04:20:33 AM
#86106   That would be nice :) vikingzskillz 08/29/15 10:33:21 AM
#86105   Good post. Trusting EPGL to keep up gman22 08/29/15 10:32:21 AM
#86104   I hope that Coopervision will talk about their franck92 08/29/15 10:31:43 AM
#86102   We all know the challenge should expect no vikingzskillz 08/29/15 10:05:48 AM
#86101   yes, Negociations seem to be in a good franck92 08/29/15 09:59:06 AM
#86099   I think negociations must be quite though. If YogInvest 08/29/15 09:21:29 AM
#86098   Yes we know what EPGL ANNOUNCES, they announce KBing617 08/29/15 09:18:21 AM
#86097   Epgl has inked deal with Coopervision but sometimes franck92 08/29/15 09:15:28 AM
#86096   Twitter Update 8/19/15 - > It seems that vikingzskillz 08/29/15 08:32:06 AM
#86095   "The Smart Case" which takes today's average contact vikingzskillz 08/29/15 08:29:57 AM
#86094   As previously disclosed EPGL owns 100% of certain vikingzskillz 08/29/15 08:29:09 AM
#86093   SMART CASE a blockbuster accessory product technology vikingzskillz 08/29/15 08:27:36 AM
#86092   EPGL and AT&T in Two-Year Development Agreement for vikingzskillz 08/29/15 08:26:36 AM
#86091   FACT PATENT FILING $COO + $EPGL + Luke vikingzskillz 08/29/15 08:25:56 AM
#86090   "We know we are ahead of Google and vikingzskillz 08/29/15 08:24:43 AM
#86089   For the first time, EPGL is revealing specifically vikingzskillz 08/29/15 08:18:09 AM
#86088   Questions are one thing, but to say day vikingzskillz 08/29/15 08:14:57 AM
#86087   Facts with links that new investors can research vikingzskillz 08/29/15 08:12:01 AM
#86086   There's a lot of condescending remarks when it skorz 08/29/15 08:09:47 AM
#86085   People can look at a posters history and vikingzskillz 08/29/15 08:07:08 AM
#86084   As with everything epgl says about empty suits KBing617 08/29/15 08:05:26 AM
#86083   Its obvious to anybody and everybody that knows H8ster 08/29/15 04:18:00 AM
#86082   For some naysayers no evidence is enough. Your kura 08/28/15 08:18:14 PM
#86081   About time the naysayers be reminded what they epglholder 08/28/15 07:20:09 PM
#86080   I am talking about the history and comments vikingzskillz 08/28/15 07:11:00 PM
#86078   rewind 2012-2014 and review the daily complaining and vikingzskillz 08/28/15 06:55:11 PM
#86077   Huh KBing617 08/28/15 06:52:26 PM
#86076   yet we not only have 1 development agreement vikingzskillz 08/28/15 06:49:56 PM
#86074   No i dont believe they have, KBing617 08/28/15 06:31:16 PM
#86073   Those trying to persuade others to sell vikingzskillz 08/28/15 06:03:27 PM
#86072   "Oh no, I' am worried bout my $EPGL Doubledown22 08/28/15 05:58:37 PM
#86071   Source is 100% trustful, EPGL, and I am vikingzskillz 08/28/15 05:54:49 PM
#86070   Ummm you do realize that PriceWaterhouseCoopers (PWC) IS Doubledown22 08/28/15 05:43:54 PM
#86069   he's just reminding the board about what the YogInvest 08/28/15 05:19:25 PM
#86068   I'M getting nerves what will be there next baryoboy 08/28/15 05:07:03 PM
#86067   I agree. I'm uncomfortable with this tweet to skorz 08/28/15 04:58:41 PM
#86066   Thats great for you, im happy for you KBing617 08/28/15 04:20:19 PM
#86065   I JUST WOULD LIKE THEM TO BE MORE baryoboy 08/28/15 04:19:20 PM
#86064   It sound, you well informed. Digra Ive 08/28/15 03:46:15 PM
#86063   I agree. Thanks EPGL for the continued Hank Kerchief 08/28/15 03:28:40 PM
#86062   My inherited shares r good.. Glad EPGL is traderwithsense 08/28/15 03:04:59 PM
#86061   KB617. ,i just sold my Ferrari ,i will Quynhnhu 08/28/15 02:56:59 PM
#86060   Glad ive been holding shares over a year mtorruiso 08/28/15 02:18:28 PM
#86059   Thanks for the reply EPGL! Now I hope gindarandhawa 08/28/15 02:17:06 PM
#86058   It should make the pps go up. dpaul007 08/28/15 02:11:59 PM
#86057   $1.1 billion up front was what EPGL opened Mrzach3590 08/28/15 02:06:44 PM
#86056   Any ideas as To what a licensing deal Bang1069 08/28/15 02:04:17 PM
#86055   "progress in patent prosecution of corporations" Stock Barber 08/28/15 01:47:25 PM
#86053   Please someone explain what's "progress in patent prosecution WhymeMA 08/28/15 01:31:07 PM
#86052   Stocks don't rise %10,000 and hold %5000+ over vikingzskillz 08/28/15 01:28:05 PM
PostSubject